Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/2B7C7DFD.svg?ark=w1%2F20260515%2F2B7C7DFD)](https://nobleid.org/work/w1/20260515/2B7C7DFD)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors